Alzheimer drug was approved by the FDA.
Drug is so expensive it raised Medicare costs.
Drug is based on attacking plaques derived from mouse studies on alzheimers.
Turns out the mice plaque model is not an accurate representation of neural degeneration in alzheimers patients.
Entire field has been stuck on a false precept.